UBS AM
IDYA icon

UBS AM’s IDEAYA Biosciences IDYA Stock Holding History

UBS AM’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.34M Sell
143,285
-31,866
-18% -$975K ﹤0.01% 1577
2026
Q1 		$5.84M Buy
175,151
+1,027
+0.6% +$34.5K ﹤0.01% 1495
2025
Q4 		$6.02M Sell
174,124
-27,319
-14% -$871K ﹤0.01% 1370
2025
Q3 		$5.48M Sell
201,443
-71,217
-26% -$1.72M ﹤0.01% 1328
2025
Q2 		$5.73M Sell
272,660
-30,485
-10% -$585K ﹤0.01% 1649
2025
Q1 		$4.97M Sell
303,145
-20,141
-6% -$429K ﹤0.01% 1581
2024
Q4 		$8.31M Buy
323,286
+4,790
+2% +$136K ﹤0.01% 1338
2024
Q3 		$10.1M Buy
318,496
+6,219
+2% +$236K ﹤0.01% 1214
2024
Q2 		$11M Buy
312,277
+80,759
+35% +$3.2M ﹤0.01% 1091
2024
Q1 		$10.2M Sell
231,518
-42,583
-16% -$1.83M ﹤0.01% 986
2023
Q4 		$9.75M Buy
274,101
+3,710
+1% +$111K ﹤0.01% 992
2023
Q3 		$7.3M Buy
+270,391
New +$6.86M ﹤0.01% 1062
2023
Q1 		– Sell
-32,072
Closed -$583K – 2694
2022
Q4 		$583K Buy
32,072
+16,999
+113% +$286K ﹤0.01% 2117
2022
Q3 		$225K Buy
15,073
+4,973
+49% +$64.6K ﹤0.01% 2573
2022
Q2 		$139K Hold
10,100
– – ﹤0.01% 2619
2022
Q1 		$113K Hold
10,100
– – ﹤0.01% 2731
2021
Q4 		$239K Buy
+10,100
New +$235K ﹤0.01% 2732

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

UBS AM's IDYA Position: Q2 2026 in Review

UBS AM reduced its IDEAYA Biosciences (IDYA) stake by 18% in Q2 2026, selling an estimated $975K and leaving 143,285 shares worth $5.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

UBS AM first reported a position in IDYA in Q4 2021 and has held it in 17 quarters since. The position peaked at $11M in Q2 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • UBS AM held 143,285 shares of IDEAYA Biosciences worth $5.34M as of Q2 2026.
  • UBS AM sold 31,866 IDEAYA Biosciences shares in Q2 2026, an estimated $975K.
  • IDEAYA Biosciences made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1577 holding.
  • UBS AM first reported a position in IDEAYA Biosciences in Q4 2021 and has held it in 17 quarters since.
  • UBS AM's IDEAYA Biosciences position peaked at $11M in Q2 2024.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.